HEART Score Calculator

Clinical calculation support · Verify results before clinical use

Clinical risk assessment

Select one option for each HEART Score component. Each component contributes 0–2 points.

0Score / 10
History

Clinical history and symptom characteristics; clinician-assessed suspicion for ACS.

0–2 points
ECG

Assess ST-segment deviation and repolarization abnormalities in clinical context.

0–2 points
Age

Use the patient's age in completed years.

0–2 points
Risk factors

Traditional risk factors include hypertension, hypercholesterolemia, diabetes, obesity, smoking, and relevant family history; known atherosclerotic disease also qualifies for 2 points.

0–2 points
Troponin

Compare the initial troponin result with the assay-specific upper reference limit (URL). Apply the assay and pathway used by your institution.

0–2 points
0HEART / 10
Risk category
Low risk
Observed 6-week MACE rate in the original prospective validation cohort: 1.7%.
Clinical context

A low score may support consideration of early discharge only when the overall assessment and an appropriate chest-pain pathway support this decision.

These event rates come from a specific validation cohort and are not a guaranteed individual risk estimate. HEART Score alone does not rule out ACS or replace serial troponin testing, repeat ECGs when indicated, or clinician judgement.

About the HEART Score

The HEART Score is a bedside risk-stratification instrument for patients presenting to the emergency department with chest pain and possible acute coronary syndrome. It scores five domains—History, ECG, Age, Risk factors, and Troponin—from 0 to 2 points each, for a total of 0–10.

Scoring criteria

Component0 points1 point2 points
HistorySlightly suspiciousModerately suspiciousHighly suspicious
ECGNormalNon-specific repolarization disturbanceSignificant ST deviation
Age<45 years45–64 years≥65 years
Risk factorsNone known1–2 risk factors≥3 risk factors or known atherosclerosis
Troponin≤ assay URL>URL to 3× URL>3× URL

Risk groups in the original prospective validation study

Total scoreRisk group6-week MACE in cohort
0–3Low1.7%
4–6Intermediate16.6%
7–10High50.1%

Event rates vary by population, assay, outcome definition, and care pathway. These figures describe the cited cohort and should not be presented as universal 30-day probabilities.

Important limitations

  • Do not use this score to delay emergency reperfusion for suspected STEMI or to override haemodynamic instability or other high-risk clinical features.
  • A low HEART score does not independently exclude myocardial infarction. Follow a locally validated pathway, including serial high-sensitivity or conventional troponin testing when indicated.
  • Troponin interpretation must use the relevant assay-specific reference limit and sampling protocol.

References

Backus BE, Six AJ, Kelder JC, et al. A prospective validation of the HEART score for chest pain patients at the emergency department. International Journal of Cardiology. 2013;168(3):2153–2158. DOI: 10.1016/j.ijcard.2013.01.255. PubMed record
Six AJ, Cullen L, Backus BE, et al. The HEART score for the assessment of patients with chest pain in the emergency department: a multinational validation study. Critical Pathways in Cardiology. 2013;12(3):121–126. DOI: 10.1097/HPC.0b013e31828b327e. PubMed record
Gulati M, Levy PD, Mukherjee D, et al. 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the Evaluation and Diagnosis of Chest Pain. Journal of the American College of Cardiology. DOI: 10.1016/j.jacc.2021.07.053. Official journal guideline
Clinical disclaimer: This calculator is intended for clinical education and decision support. It does not replace a complete clinical assessment or a validated local acute chest-pain pathway. Interpret the result in the context of symptoms, haemodynamic status, ECG findings, assay-specific troponin results and their change over time, comorbidities, and clinician judgement.